BR9406496A - Processo e composição para estimulação do sistema imunológico em um ser humano ou animal - Google Patents

Processo e composição para estimulação do sistema imunológico em um ser humano ou animal

Info

Publication number
BR9406496A
BR9406496A BR9406496A BR9406496A BR9406496A BR 9406496 A BR9406496 A BR 9406496A BR 9406496 A BR9406496 A BR 9406496A BR 9406496 A BR9406496 A BR 9406496A BR 9406496 A BR9406496 A BR 9406496A
Authority
BR
Brazil
Prior art keywords
stimulating
animal
human
immune system
composition
Prior art date
Application number
BR9406496A
Other languages
English (en)
Inventor
Stanley J Alkemade
Graeme Mcrae
Original Assignee
Vetrepharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetrepharm Inc filed Critical Vetrepharm Inc
Publication of BR9406496A publication Critical patent/BR9406496A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
BR9406496A 1993-01-29 1994-01-28 Processo e composição para estimulação do sistema imunológico em um ser humano ou animal BR9406496A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1165593A 1993-01-29 1993-01-29
PCT/CA1994/000054 WO1994016727A1 (en) 1993-01-29 1994-01-28 Immunotherapeutic composition

Publications (1)

Publication Number Publication Date
BR9406496A true BR9406496A (pt) 1996-01-02

Family

ID=21751403

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9406496A BR9406496A (pt) 1993-01-29 1994-01-28 Processo e composição para estimulação do sistema imunológico em um ser humano ou animal

Country Status (11)

Country Link
US (1) US5759554A (pt)
EP (1) EP0681479B1 (pt)
JP (1) JPH08508976A (pt)
CN (1) CN1102855C (pt)
AT (1) ATE179333T1 (pt)
AU (1) AU691797B2 (pt)
BR (1) BR9406496A (pt)
DE (1) DE69418183T2 (pt)
DK (1) DK0681479T3 (pt)
NZ (1) NZ261094A (pt)
WO (1) WO1994016727A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO359396A0 (en) * 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
EP0971721A1 (en) * 1997-04-02 2000-01-19 Bioniche Inc. Use of bacterial cell wall extract for preventing, treating, or eliminating a protozoal or parasitic disease
JP4335435B2 (ja) 1997-08-05 2009-09-30 バイオニケ ライフ サイエンシーズ インコーポレイテッド 細胞増殖および細胞死を調節する組成物および方法
ATE273027T1 (de) * 1998-12-04 2004-08-15 Bioniche Life Sciences Inc Zusammensetzung zur behandlung von entzündungen
US6809081B1 (en) * 1998-12-04 2004-10-26 Bioniche Life Sciences, Inc. Chemotherapeutic composition and method
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
ATE353660T1 (de) * 1999-07-23 2007-03-15 Bioniche Life Sciences Inc Methode zur steigerung der produktionsleistung in tieren
US6890541B1 (en) 1999-07-23 2005-05-10 Bioniche Life Sciences, Inc. Method for enhancing production performance in an animal
PT1238070E (pt) * 1999-12-13 2007-11-06 Bioniche Life Sciences Inc Oligonucleótidos sintéticos úteis sob o ponto de vista terapêutico
EP1250152B1 (en) 1999-12-28 2013-05-15 Bioniche Urology IP Inc. Synergistic composition containing hyaluronic acid in the treatment of cancer
CN1981868A (zh) * 2000-03-31 2007-06-20 拜奥根Idec公司 抗细胞因子抗体或拮抗剂与抗－cd20在b细胞淋巴瘤治疗中的联合应用
JP5578390B2 (ja) * 2007-03-05 2014-08-27 株式会社 Ｍｂｒ 細菌細胞壁骨格成分の製造方法
AU2011315093B2 (en) 2010-10-13 2013-10-17 Telesta Therapeutics Ip Inc. Bacterial ribonucleic acid cell wall compositions and methods of making and using them
TR201101874A2 (tr) 2011-02-25 2011-08-22 Leyla A�An Nac�Ye Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri.
SG11201606677XA (en) * 2014-02-18 2016-09-29 Advaxis Inc Biomarker directed multi-target immunotherapy
AU2017222692A1 (en) * 2016-02-25 2018-09-27 Thomas Julius Borody Compositions and methods of treatment of chronic infectious diseases
IT202000002866A1 (it) 2020-02-13 2021-08-13 Altergon Sa Composizioni antivirali
CN113244384A (zh) 2020-02-11 2021-08-13 阿尔特刚股份有限公司 抗病毒组合物
IT202000002641A1 (it) 2020-02-11 2021-08-11 Altergon Sa Composizioni antivirali
IT202100013292A1 (it) * 2021-05-21 2022-11-21 Aileens Pharma S R L Parete cellulare batterica legata a mucopolisaccaride suoi utilizzi e processo per la sua produzione

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) * 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections
US3331741A (en) * 1964-12-03 1967-07-18 Warner Lambert Pharmaceutical Process for the preparation of a soluble bacterial extract
FR2160326B1 (pt) * 1971-11-19 1975-02-07 Anvar
NL7308450A (pt) * 1972-06-20 1973-12-27
CH602920A5 (pt) * 1973-02-23 1978-08-15 Wellcome Found
US4069314A (en) * 1973-02-23 1978-01-17 Christopher Adlam Glycopeptide extract
FR2269961B1 (pt) * 1974-05-06 1978-03-24 Anvar
FR2320107A1 (fr) * 1975-08-05 1977-03-04 Anvar Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
US4340586A (en) * 1977-02-18 1982-07-20 Adam Bekierkunst Pharmaceutical preparation for treating disorders of the skin
US4504473A (en) * 1982-06-30 1985-03-12 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4503048A (en) * 1982-06-30 1985-03-05 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4505903A (en) * 1982-06-30 1985-03-19 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
FR2551758B1 (fr) * 1983-08-16 1986-01-31 Anvar Derives de muramyl-peptides et de steroides ayant des proprietes d'activation des macrophages
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
FR2662942B1 (fr) * 1990-06-06 1992-09-18 Neway Tsehay Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
CA2095855C (en) * 1990-11-08 2003-04-29 Graham A.W. Rook Mycobacterium as adjuvant for antigens

Also Published As

Publication number Publication date
CN1102855C (zh) 2003-03-12
ATE179333T1 (de) 1999-05-15
AU691797B2 (en) 1998-05-28
DE69418183T2 (de) 1999-12-16
AU5968094A (en) 1994-08-15
CN1118574A (zh) 1996-03-13
WO1994016727A1 (en) 1994-08-04
NZ261094A (en) 1998-04-27
EP0681479A1 (en) 1995-11-15
DK0681479T3 (da) 1999-11-08
JPH08508976A (ja) 1996-09-24
DE69418183D1 (de) 1999-06-02
US5759554A (en) 1998-06-02
EP0681479B1 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
DE69418183D1 (de) Immunotherapeutische zubereitung
DE3684305D1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
EP0206529A3 (en) Treatment of oral diseases
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
ES2190784T3 (es) Supresion de enfermedades autoinmunes por antigenos espectadores.
CA2132953A1 (en) Monospecific polyclonal antibodies to shiga-like toxins
BR8803442A (pt) Polissacarideo,processo para a preparacao de polissacarideos,medicamento para uso humano ou animal e aditivo alimentar
IL68350A0 (en) N-glycosylated carboxamide derivatives,their preparation and their use for the treatment of animals
ES2164434T3 (es) Tratamiento topico de psoriasis que utiliza anticuerpos neutralizantes de il-8.
EP0308197A3 (en) Method for stimulating the immune system
ATE1443T1 (de) Mittel zur behandlung allergischer reaktionen.
ES2177535T3 (es) Vacunas contra protozoos intestinales.
ATE359814T1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
ES556684A0 (es) Un procedimiento para tratar celulas efectoras que tienen receptores de superficie para la region fc de un anticuerpo
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
CA2154689A1 (en) Improved immunotherapeutic composition
BR9305075A (pt) Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
DE3373978D1 (en) Composition for the care or treatment of the human skin
AU562828B2 (en) Morphine-vitamin b12 analgesic treatment
SE8200748L (sv) Terapeutiskt medel
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ATE202284T1 (de) Ein extrakt aus muscheln, extraktionsmethoden und verwendungen davon

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal